CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: A Study of Guselkumab in Participants With Systemic Sclerosis [Phase 2]
Summary
This Phase 2 clinical trial evaluating guselkumab in systemic sclerosis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Scleroderma, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09